Wambolt & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$809K Sell
1,919
-248
-11% -$105K 0.27% 95
2025
Q1
$1.05M Sell
2,167
-50
-2% -$24.2K 0.36% 82
2024
Q4
$1.15M Buy
2,217
+2
+0.1% +$1.04K 0.37% 81
2024
Q3
$1.36M Sell
2,215
-38
-2% -$23.3K 0.37% 81
2024
Q2
$1.22M Sell
2,253
-8
-0.4% -$4.33K 0.35% 80
2024
Q1
$1.31M Sell
2,261
-3
-0.1% -$1.73K 0.39% 81
2023
Q4
$1.2M Sell
2,264
-13
-0.6% -$6.9K 0.39% 86
2023
Q3
$1.13M Buy
2,277
+54
+2% +$26.8K 0.41% 84
2023
Q2
$1.16M Buy
2,223
+2
+0.1% +$1.04K 0.41% 88
2023
Q1
$1.27M Sell
2,221
-50
-2% -$28.5K 0.45% 79
2022
Q4
$1.25M Sell
2,271
-6
-0.3% -$3.3K 0.48% 78
2022
Q3
$1.16M Sell
2,277
-11
-0.5% -$5.58K 0.49% 78
2022
Q2
$1.24M Sell
2,288
-43
-2% -$23.4K 0.5% 66
2022
Q1
$1.38M Buy
2,331
+12
+0.5% +$7.11K 0.5% 72
2021
Q4
$1.55M Sell
2,319
-12
-0.5% -$8.01K 0.56% 63
2021
Q3
$1.34M Buy
2,331
+46
+2% +$26.3K 0.54% 66
2021
Q2
$1.16M Buy
2,285
+25
+1% +$12.7K 0.49% 72
2021
Q1
$1.03M Sell
2,260
-20
-0.9% -$9.12K 0.54% 69
2020
Q4
$1.06M Hold
2,280
0.63% 54
2020
Q3
$1.01M Sell
2,280
-81
-3% -$35.8K 0.75% 41
2020
Q2
$855K Sell
2,361
-2
-0.1% -$724 0.67% 48
2020
Q1
$670K Sell
2,363
-105
-4% -$29.8K 0.69% 45
2019
Q4
$802K Sell
2,468
-25
-1% -$8.12K 0.61% 53
2019
Q3
$726K Hold
2,493
0.6% 55
2019
Q2
$732K Sell
2,493
-10
-0.4% -$2.94K 0.62% 51
2019
Q1
$695K Buy
2,503
+1,103
+79% +$306K 0.63% 46
2018
Q4
$313K Buy
+1,400
New +$313K 0.35% 100